DR. KHURRAM MAHMOOD CHAUDHARY M.D.
Prescription History 1306088521
Ophthalmology - Retina Specialist in East Setauket, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. KHURRAM MAHMOOD CHAUDHARY M.D., an active Retina Specialist specialist practicing in East Setauket, NY. Our medical registry currently tracks 16 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 953 documented patient claims. Among these therapy options, the most frequently utilized medication is Eylea, which accounts for 547 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| EyleaAflibercept | 547 | $2,322.67▼ below NY avg | ▲ More than typical |
About Eylea: Aflibercept is used to treat certain serious eye conditions (such as macular edema/degeneration, diabetic retinopathy, retinopathy of prematurity). Show more ▾ This medication can help preserve vision and prevent blindness. Aflibercept belongs to a class of drugs known as growth factor inhibitors. It works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels. This monograph is about the following aflibercept products: aflibercept, aflibercept-ayyh. Has antiangiogenic activity; consists of the second and third Ig domains of VEGFR1 and VEGFR2, respectively, fusion to the Fc region of IgG1; putative antineoplastic agent that binds all VEGF-A isoforms; possible medicine for eye disorders. In 2024, this provider wrote 547 Medicare prescriptions for Eylea, about 7.1 times the volume of the typical New York prescriber of this medication (76.7). Medicare paid an average of $2,322.67 per fill, versus $2,453.55 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 548.8 30-Day Fills standardized to 30-day supplies 15,518 Days of Medication total across all patients in 2024 | |||
| Prednisolone Acetate | 109 | $63.13 | ≈ Typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. In 2024, this provider wrote 109 Medicare prescriptions for Prednisolone Acetate, about 77% of the volume of the typical New York prescriber of this medication (141.0). Medicare paid an average of $63.13 per fill, versus $43.48 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 203 30-Day Fills standardized to 30-day supplies 5,987 Days of Medication total across all patients in 2024 | |||
| Ketorolac Tromethamine | 83 | $19.06▼ below NY avg | ≈ Typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2024, this provider wrote 83 Medicare prescriptions for Ketorolac Tromethamine, about 83% of the volume of the typical New York prescriber of this medication (100.6). Medicare paid an average of $19.06 per fill, versus $21.99 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 100 30-Day Fills standardized to 30-day supplies 2,486 Days of Medication total across all patients in 2024 | |||
| VabysmoFaricimab-Svoa | 31 | $2,704.29▼ below NY avg | ▼ Less than typical |
About Vabysmo: Faricimab is used to treat certain serious eye conditions (such as wet age-related macular degeneration, macular edema). Show more ▾ It is used to help prevent decreased vision and blindness. Faricimab works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels. In 2024, this provider wrote 31 Medicare prescriptions for Vabysmo, about 75% of the volume of the typical New York prescriber of this medication (41.6). Medicare paid an average of $2,704.29 per fill, versus $2,835.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 31 30-Day Fills standardized to 30-day supplies 868 Days of Medication total across all patients in 2024 | |||
| OzurdexDexamethasone | 21 | $1,615.95▼ below NY avg | ≈ Typical |
About Ozurdex: An anti-inflammatory 9-fluoro-glucocorticoid. In 2024, this provider wrote 21 Medicare prescriptions for Ozurdex, about 84% of the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $1,615.95 per fill, versus $1,744.07 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 61.4 30-Day Fills standardized to 30-day supplies 1,842 Days of Medication total across all patients in 2024 | |||
| IzervayAvacincaptad Pegol Sodium/Pf | 20 | $3,310.40 | – No State Data |
About Izervay: Avacincaptad pegol is used to treat a certain serious eye condition (geographic atrophy). Show more ▾ It may help delay vision loss. Avacincaptad pegol works by helping to block your immune system from destroying cells in your eye. In 2024, this provider wrote 20 Medicare prescriptions for Izervay. Medicare paid an average of $3,310.40 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $3,310.40 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Ofloxacin | 20 | $15.40▼ below NY avg | ▼ Less than typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2024, this provider wrote 20 Medicare prescriptions for Ofloxacin, about a third of the volume of the typical New York prescriber of this medication (63.3). Medicare paid an average of $15.40 per fill, versus $17.39 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 26.2 30-Day Fills standardized to 30-day supplies 698 Days of Medication total across all patients in 2024 | |||
| Latanoprost | 18 | $7.20▼ below NY avg | ▼ Less than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 18 Medicare prescriptions for Latanoprost, about 11% of the volume of the typical New York prescriber of this medication (159.1). Medicare paid an average of $7.20 per fill, versus $11.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 29 30-Day Fills standardized to 30-day supplies 850 Days of Medication total across all patients in 2024 | |||
| LucentisRanibizumab | 16 | $2,696.88 | – No State Data |
About Lucentis: This medication is used to treat certain serious eye conditions (such as age-related macular degeneration, macular edema, diabetic retinopathy). Show more ▾ It is used to help prevent decreased vision and blindness. Ranibizumab works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels. This monograph is about the following ranibizumab products: ranibizumab, ranibizumab-eqrn, and ranibizumab-nuna. A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION. In 2024, this provider wrote 16 Medicare prescriptions for Lucentis. Medicare paid an average of $2,696.88 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $2,696.88 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 464 Days of Medication total across all patients in 2024 | |||
| Bromfenac Sodium | 14 | $126.56▼ below NY avg | ▼ Less than typical |
About Bromfenac Sodium: This medication is used to treat swelling (inflammation) and pain in the eye after a certain type of eye surgery (cataract surgery). Show more ▾ Bromfenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking the effects of certain natural substances (prostaglandins) that cause pain and inflammation. In 2024, this provider wrote 14 Medicare prescriptions for Bromfenac Sodium, about a quarter of the volume of the typical New York prescriber of this medication (52.1). Medicare paid an average of $126.56 per fill, versus $164.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 14 30-Day Fills standardized to 30-day supplies 224 Days of Medication total across all patients in 2024 | |||
| Atropine Sulfate | 13 | $62.02 | ▼ Less than typical |
About Atropine Sulfate: This medication is used before eye examinations (such as refraction) and to treat certain eye conditions (such as uveitis). Show more ▾ It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye. An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine. In 2024, this provider wrote 13 Medicare prescriptions for Atropine Sulfate, about half the volume of the typical New York prescriber of this medication (25.9). Medicare paid an average of $62.02 per fill, versus $40.20 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28.6 30-Day Fills standardized to 30-day supplies 857 Days of Medication total across all patients in 2024 | |||
| Dorzolamide Hcl | 13 | $9.38▼ below NY avg | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. Topically effective ocular hypotensive carbonic anhydrase inhibitor. In 2024, this provider wrote 13 Medicare prescriptions for Dorzolamide Hcl, about a quarter of the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $9.38 per fill, versus $19.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 17.7 30-Day Fills standardized to 30-day supplies 531 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 13 | $19.44 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 13 Medicare prescriptions for Dorzolamide-Timolol, about 13% of the volume of the typical New York prescriber of this medication (102.4). Medicare paid an average of $19.44 per fill, versus $17.98 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31.5 30-Day Fills standardized to 30-day supplies 945 Days of Medication total across all patients in 2024 | |||
| Eylea HdAflibercept | 12 | $2,421.23▼ below NY avg | ▼ Less than typical |
About Eylea Hd: Aflibercept is used to treat certain serious eye conditions (such as macular edema/degeneration, diabetic retinopathy, retinopathy of prematurity). Show more ▾ This medication can help preserve vision and prevent blindness. Aflibercept belongs to a class of drugs known as growth factor inhibitors. It works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels. This monograph is about the following aflibercept products: aflibercept, aflibercept-ayyh. Has antiangiogenic activity; consists of the second and third Ig domains of VEGFR1 and VEGFR2, respectively, fusion to the Fc region of IgG1; putative antineoplastic agent that binds all VEGF-A isoforms; possible medicine for eye disorders. In 2024, this provider wrote 12 Medicare prescriptions for Eylea Hd, about 69% of the volume of the typical New York prescriber of this medication (17.4). Medicare paid an average of $2,421.23 per fill, versus $3,564.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 12 30-Day Fills standardized to 30-day supplies 336 Days of Medication total across all patients in 2024 | |||
| ValacyclovirValacyclovir Hcl | 12 | $164.78 | ▼ Less than typical |
About Valacyclovir: Valacyclovir is used to treat infections caused by certain types of viruses. Show more ▾ In children, it is used to treat cold sores around the mouth (caused by herpes simplex) and chickenpox (caused by varicella zoster). In adults, it is used to treat shingles (caused by herpes zoster) and cold sores around the mouth. Valacyclovir is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, this medication is used to reduce the number of future episodes. Valacyclovir is an antiviral drug. It stops the growth of certain viruses. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Valacyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. A prodrug of acyclovir that is used in the treatment of HERPES ZOSTER and HERPES SIMPLEX VIRUS INFECTION of the skin and mucous membranes, including GENITAL HERPES. In 2024, this provider wrote 12 Medicare prescriptions for Valacyclovir, about half the volume of the typical New York prescriber of this medication (24.3). Medicare paid an average of $164.78 per fill, versus $29.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 400 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 11 | $6.28▼ below NY avg | ▼ Less than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 11 Medicare prescriptions for Timolol Maleate, about 15% of the volume of the typical New York prescriber of this medication (74.4). Medicare paid an average of $6.28 per fill, versus $26.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 16.6 30-Day Fills standardized to 30-day supplies 498 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. KHURRAM MAHMOOD CHAUDHARY M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Retina Specialist prescribing approach at this East Setauket, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NY prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
